CQDM Connect-Pharma Pitch Day Call for Ideas: Obesity & Metabolic Disorders: Novel Targets and Drugs



For More Information

Program Information including Research Focus Areas, Submission form and Guidelines can be found on the CQDM website.


CQDM is searching for world-class research to develop novel and efficient approaches for obesity and metabolic disorders therapeutics to present to domain experts from leading global pharmaceutical organizations on May 23, 2024.

Their objective is to bring ground-breaking, innovative Canadian research to CQDM’s pharmaceutical members and to facilitate interactions between pharmaceutical members and the Canadian ecosystem. Collaborative projects developed with a CQDM pharmaceutical member are eligible to obtain funding via CQDM’s Quantum Leap program.

Passionate Canadian researchers and visionary teams are invited to submit innovative ideas that have the potential to transform the landscape of medicine and improve patient outcomes.


Canadian academic institutions, biotech companies and research organizations are eligible to apply. Collaborative projects that involve partnerships between academia and industry are also encouraged. We welcome multidisciplinary teams that can bring diverse expertise to the table.

How to Apply

Submit completed form directly to CQDM via email appliquez-apply@cqdm.org by April 16, 2024.

 All submitted projects will be shared with CQDM’s pharmaceutical members for review and ranking. Top ranked projects will be selected to present to CQDM's global pharmaceutical members at a CQDM Connect-Pharma: Pitch Day on May 23, 2024.


File Submission Form_CQDM_obesity.docx49.94 KB
For Questions, please contact

Simon Fournier

Email: sfournier@cqdm.org

Alert Classifications
Funding Opportunities and Sponsor News

Health and Life Sciences